165 related articles for article (PubMed ID: 25779383)
1. Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.
Vanobberghen FM; Kilama B; Wringe A; Ramadhani A; Zaba B; Mmbando D; Todd J
Trop Med Int Health; 2015 Jul; 20(7):880-92. PubMed ID: 25779383
[TBL] [Abstract][Full Text] [Related]
2. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
Hoffmann CJ; Maritz J; van Zyl GU
Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
[TBL] [Abstract][Full Text] [Related]
3. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
4. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
5. Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.
Hawkins C; Hertzmark E; Spiegelman D; Muya A; Ulenga N; Kim S; Khudyakov P; Christian B; Sando D; Aris E; Fawzi W
J Antimicrob Chemother; 2017 Jul; 72(7):2060-2068. PubMed ID: 28387836
[TBL] [Abstract][Full Text] [Related]
6. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O;
Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345
[TBL] [Abstract][Full Text] [Related]
7. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
[TBL] [Abstract][Full Text] [Related]
8. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.
Jourdain G; Le Cœur S; Ngo-Giang-Huong N; Traisathit P; Cressey TR; Fregonese F; Leurent B; Collins IJ; Techapornroong M; Banchongkit S; Buranabanjasatean S; Halue G; Nilmanat A; Luekamlung N; Klinbuayaem V; Chutanunta A; Kantipong P; Bowonwatanuwong C; Lertkoonalak R; Leenasirimakul P; Tansuphasawasdikul S; Sang-A-Gad P; Pathipvanich P; Thongbuaban S; Wittayapraparat P; Eiamsirikit N; Buranawanitchakorn Y; Yutthakasemsunt N; Winiyakul N; Decker L; Barbier S; Koetsawang S; Sirirungsi W; McIntosh K; Thanprasertsuk S; Lallemant M;
PLoS Med; 2013 Aug; 10(8):e1001494. PubMed ID: 23940461
[TBL] [Abstract][Full Text] [Related]
9. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
10. Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
Schoffelen AF; Wensing AM; Tempelman HA; Geelen SP; Hoepelman AI; Barth RE
PLoS One; 2013; 8(3):e58526. PubMed ID: 23505529
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
[TBL] [Abstract][Full Text] [Related]
12. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
[TBL] [Abstract][Full Text] [Related]
13. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP
PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695
[TBL] [Abstract][Full Text] [Related]
14. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program.
Sudsila P; Teeraananchai S; Kiertiburanakul S; Lertpiriyasuwat C; Triamwichanon R; Gatechompol S; Putcharoen O; Chetchotisakd P; Avihingsanon A; Kerr SJ; Ruxrungtham K
J Int Assoc Provid AIDS Care; 2023; 22():23259582231220513. PubMed ID: 38115729
[TBL] [Abstract][Full Text] [Related]
16. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.
Kantor R; Diero L; Delong A; Kamle L; Muyonga S; Mambo F; Walumbe E; Emonyi W; Chan P; Carter EJ; Hogan J; Buziba N
Clin Infect Dis; 2009 Aug; 49(3):454-62. PubMed ID: 19569972
[TBL] [Abstract][Full Text] [Related]
17. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
19. Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
Desmonde S; Eboua FT; Malateste K; Dicko F; Ekouévi DK; Ngbeché S; Koueta F; Sy HS; Renner L; Koumakpai SA; Leroy V;
AIDS; 2015 Jul; 29(12):1527-36. PubMed ID: 26244392
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment failure predicts mortality in rural Tanzania.
Pettersen PS; Brox IK; Naman E; Bruun JN; Dyrhol-Riise AM; Trøseid M; Johannessen A
Int J STD AIDS; 2015 Aug; 26(9):633-9. PubMed ID: 25122578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]